100 related articles for article (PubMed ID: 11896586)
1. High levels of the onco-protein Gfi-1 accelerate T-cell proliferation and inhibit activation induced T-cell death in Jurkat T-cells.
Karsunky H; Mende I; Schmidt T; Möröy T
Oncogene; 2002 Feb; 21(10):1571-9. PubMed ID: 11896586
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of CD6 expression on human T lymphocytes by phorbol ester.
Bott CM; Doshi JB; Li LL; McMurtry SA; Sanders JL; Fox DA
J Immunol; 1994 Jul; 153(1):1-9. PubMed ID: 8207228
[TBL] [Abstract][Full Text] [Related]
3. Differential impact of the transcriptional repressor Gfi1 on mature CD4+ and CD8+ T lymphocyte function.
Pargmann D; Yücel R; Kosan C; Saba I; Klein-Hitpass L; Schimmer S; Heyd F; Dittmer U; Möröy T
Eur J Immunol; 2007 Dec; 37(12):3551-63. PubMed ID: 18034420
[TBL] [Abstract][Full Text] [Related]
4. Enhanced basal AP-1 activity and de-regulation of numerous genes in T cells transgenic for a dominant interfering mutant of FADD/MORT1.
Chaneva S; Schneider G; Siegmund D; Wajant H; Mages J; Häcker G
Eur J Immunol; 2004 Nov; 34(11):3006-15. PubMed ID: 15376191
[TBL] [Abstract][Full Text] [Related]
5. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.
Schmidt T; Karsunky H; Gau E; Zevnik B; Elsässer HP; Möröy T
Oncogene; 1998 Nov; 17(20):2661-7. PubMed ID: 9840930
[TBL] [Abstract][Full Text] [Related]
6. Activation-induced expression of human programmed death-1 gene in T-lymphocytes.
Vibhakar R; Juan G; Traganos F; Darzynkiewicz Z; Finger LR
Exp Cell Res; 1997 Apr; 232(1):25-8. PubMed ID: 9141617
[TBL] [Abstract][Full Text] [Related]
7. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors.
Márquez N; Sancho R; Macho A; Calzado MA; Fiebich BL; Muñoz E
J Pharmacol Exp Ther; 2004 Mar; 308(3):993-1001. PubMed ID: 14617683
[TBL] [Abstract][Full Text] [Related]
8. Expression of the proto-oncogene rhombotin-2 is identical to the acute phase response protein metallothionein, suggesting multiple functions.
Neale GA; Mao S; Parham DM; Murti KG; Goorha RM
Cell Growth Differ; 1995 May; 6(5):587-96. PubMed ID: 7544155
[TBL] [Abstract][Full Text] [Related]
9. Anisomycin inhibits the behaviors of T cells and the allogeneic skin transplantation in mice.
Xing F; Yu Z; Liu J; Di J; Zeng S; Chen D; Chen L; Fang Z; Guo Z; Pan S; Wang J; Li Y; Hao W; Fan Z; Teng Z; Chen G; Chen Z; Mao C; Long Y; Liu N
J Immunother; 2008; 31(9):858-70. PubMed ID: 18833001
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle progression and phenotypic modification of Ki67 antigen-negative G1- and G2-phase cells in phorbol ester-treated Molt-4 human leukemia cells.
Tsurusawa M; Fujimoto T
Cytometry; 1995 Jun; 20(2):146-53. PubMed ID: 7664625
[TBL] [Abstract][Full Text] [Related]
11. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells.
De Fanis U; Romano C; Dalla Mora L; Sellitto A; Guastafierro S; Tirelli A; Bresciano E; Giunta R; Lucivero G
Oncol Rep; 2003; 10(3):653-8. PubMed ID: 12684639
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.
Checker R; Sharma D; Sandur SK; Khanam S; Poduval TB
Int Immunopharmacol; 2009 Jul; 9(7-8):949-58. PubMed ID: 19374955
[TBL] [Abstract][Full Text] [Related]
13. The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit+ T cell progenitors and CD4/CD8 lineage decision in the thymus.
Yücel R; Karsunky H; Klein-Hitpass L; Möröy T
J Exp Med; 2003 Apr; 197(7):831-44. PubMed ID: 12682108
[TBL] [Abstract][Full Text] [Related]
14. Induction of lysosomal and plasma membrane-bound sialidases in human T-cells via T-cell receptor.
Wang P; Zhang J; Bian H; Wu P; Kuvelkar R; Kung TT; Crawley Y; Egan RW; Billah MM
Biochem J; 2004 Jun; 380(Pt 2):425-33. PubMed ID: 14992689
[TBL] [Abstract][Full Text] [Related]
15. The role of ERK5 in T-cell signalling.
Garaude J; Kaminski S; Cherni S; Hipskind RA; Villalba M
Scand J Immunol; 2005 Dec; 62(6):515-20. PubMed ID: 16316418
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase D2 contributes to either IL-2 promoter regulation or induction of cell death upon TCR stimulation depending on its activity in Jurkat cells.
Irie A; Harada K; Tsukamoto H; Kim JR; Araki N; Nishimura Y
Int Immunol; 2006 Dec; 18(12):1737-47. PubMed ID: 17077180
[TBL] [Abstract][Full Text] [Related]
17. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
18. MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells and normal T cells.
Mukherjee P; Tinder TL; Basu GD; Gendler SJ
J Leukoc Biol; 2005 Jan; 77(1):90-9. PubMed ID: 15513966
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
[TBL] [Abstract][Full Text] [Related]
20. Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells.
Jin ZX; Huang CR; Dong L; Goda S; Kawanami T; Sawaki T; Sakai T; Tong XP; Masaki Y; Fukushima T; Tanaka M; Mimori T; Tojo H; Bloom ET; Okazaki T; Umehara H
Int Immunol; 2008 Nov; 20(11):1427-37. PubMed ID: 18820264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
